APP and Alzheimer disease: COXd/AD mice show reduced expression of AβPP and COXI when compared with control AD mice, while the frequency of Aβ plaques and 8OHG+ oxidized nuclei were also reduced [49], tempting to speculate on the impact of mitochondrial-derived compounds in AD progression.